These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Movement disorders in patients treated with long-acting injectable antipsychotic drugs. Bransgrove LL, Kelly MW. Am J Hosp Pharm; 1994 Apr 01; 51(7):895-9. PubMed ID: 7912473 [Abstract] [Full Text] [Related]
4. Antipsychotic medication: clinical guidelines for maintenance therapy. Johnson DA. J Clin Psychiatry; 1985 May 01; 46(5 Pt 2):6-15. PubMed ID: 2859281 [Abstract] [Full Text] [Related]
5. A comparison of antipsychotic drug-defined daily doses versus chlorpromazine equivalent doses in patients with or without extrapyramidal motor symptoms. Barr AM, Honer WG, Johnson JL, Wu TK, Procyshyn RM. J Clin Psychopharmacol; 2010 Dec 01; 30(6):741-3. PubMed ID: 21057241 [No Abstract] [Full Text] [Related]
6. Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises. Sachdev P, Tang WM. Aust N Z J Psychiatry; 1992 Dec 01; 26(4):666-70. PubMed ID: 1362053 [Abstract] [Full Text] [Related]
13. [Effects and complications of neuroleptics (110 hospitalizations in neurology)]. Destee A, Montagne B, Rousseaux M, Petit H, Warot P. Lille Med; 1980 May 01; 25(6):291-5. PubMed ID: 6105602 [No Abstract] [Full Text] [Related]
15. Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychoses. McConville BJ, Sorter MT. J Clin Psychiatry; 2004 May 01; 65 Suppl 6():20-9. PubMed ID: 15104523 [Abstract] [Full Text] [Related]
20. The handwriting test as an aid to neuroleptic dosage. Küstner U, Müller-Oerlinghausen B. Int J Clin Pharmacol Ther Toxicol; 1985 Apr 01; 23 Suppl 1():S34-41. PubMed ID: 2878893 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]